). These differences may be partly explained by variations between drugs in patterns of absorption, distribution, and elimination Shader and Greenblatt, 1977) . This paper reviews how these pharmacokinetic differences may influence apparent clinical action.
SINGLE DOSES
The rate of onset and duration of action of a single dose of a benzodiazepine derivative is of importance in some but not all clinical situations (Breimer, 1979; Curry and Whelpton, 1979) . Rapid onset of action is desirable for patients taking a benzodiazepine as a bedtime hypnotic, or in those experiencing acute anxiety who require rapid relief of symptoms. On the other hand, a slow onset of action is more desirable for patients who perceive the acute effects of single doses as unwanted drowsiness, sedation, or a feeling of being "spaced out". It is hypothesized that those benzodiazepines most prone to abuse by pleasure-seeking individuals are those with the most rapid onset of action, which abusers perceive as a "rush" or "high".
The most important determinant of onset of action is rate of absorption from the gastrointestinal tract. The most rapidly absorbed drugs are those that dissolve quickly in the stomach. Diazepam and clorazepate (serving as a precursor of desmethyl-diazepam) are notorious for their rapid onset of action. Prazepam (also a precursor of desmethyldiazepam), oxazepam, and temazepam, are slowly absorbed drugs.
Chlordiazepoxide and lorazepam fall somewhere in between. These differences should be considered when a particular drug is chosen to meet the needs of an individual patient. It should be remembered that most of our knowledge of drug absorption rates is based on pharmacokinetic studies using volunteers in the fasting state with nothing in their stomach. Ingestion of benzodiazepines with food or with antacids can slow the rate of absorption, and thereby reduce the onset and intensity of clinical effects following single doses Table 2 summarizes the comparative properties of these two classes of benzodiazepines. COMMENTS Understanding of pharmacokinetic differences among benzodiazepine derivatives may help clinicians in their attempt to choose the right drugs and dosage to meet the needs of a given patient. Pharmacokinetics, however, does not tell the whole story, due to unpredictable differences among individuals in response to drugs. The most important factor in optimizing anxiolytic therapy still remains the clinical judgement and the careful monitoring of the treating physician.
